Global Glycobiology Market 2022-2026

The publisher has been monitoring the glycobiology market and it is poised to grow by $ 1.13 bn during 2022-2026, progressing at a CAGR of 14.84% during the forecast period. This report on the glycobiology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of cancer and it is anticipated to boost the growth of the market as well.

The glycobiology market analysis includes the application segment and geographic landscape.

The glycobiology market is segmented as below:

By Application

Drug discovery and development
Disease diagnostics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in the field of glycobiology as one of the prime reasons driving the glycobiology market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

This report on the glycobiology market covers the following areas:

Glycobiology market sizing
Glycobiology market forecast
Glycobiology market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading glycobiology market vendors that include Agilent Technologies Inc., Asparia Glycomics S.L., Bio-Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, Glycosensors and Diagnostics LLC, ICE S.p.A., Ludger Ltd, Merck KGaA, New England Biolabs Inc., Plexera LLC, RayBiotech Life Inc., Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., and Z Biotech LLC. Also, the glycobiology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Drug discovery and development - Market size and forecast 2021-2026
Exhibit 28: Chart on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Drug discovery and development - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Drug discovery and development - Year-over-year growth 2021-2026 (%)
5.4 Disease diagnostics - Market size and forecast 2021-2026
Exhibit 32: Chart on Disease diagnostics - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Disease diagnostics - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Disease diagnostics - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Disease diagnostics - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Application
Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 Market opportunity By Geographical Landscape
Exhibit 62: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 63: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 64: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 65: Overview on factors of disruption
9.4 Industry risks
Exhibit 66: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 67: Vendors covered
10.2 Market positioning of vendors
Exhibit 68: Matrix on vendor position and classification
10.3 Agilent Technologies Inc.
Exhibit 69: Agilent Technologies Inc. - Overview
Exhibit 70: Agilent Technologies Inc. - Business segments
Exhibit 71: Agilent Technologies Inc. - Key news
Exhibit 72: Agilent Technologies Inc. - Key offerings
Exhibit 73: Agilent Technologies Inc. - Segment focus
10.4 Asparia Glycomics S.L.
Exhibit 74: Asparia Glycomics S.L. - Overview
Exhibit 75: Asparia Glycomics S.L. - Product/Service
Exhibit 76: Asparia Glycomics S.L. - Key offerings
10.5 Bio Techne Corp.
Exhibit 77: Bio Techne Corp. - Overview
Exhibit 78: Bio Techne Corp. - Business segments
Exhibit 79: Bio Techne Corp. - Key news
Exhibit 80: Bio Techne Corp. - Key offerings
Exhibit 81: Bio Techne Corp. - Segment focus
10.6 Merck KGaA
Exhibit 82: Merck KGaA - Overview
Exhibit 83: Merck KGaA - Business segments
Exhibit 84: Merck KGaA - Key news
Exhibit 85: Merck KGaA - Key offerings
Exhibit 86: Merck KGaA - Segment focus
10.7 New England Biolabs Inc.
Exhibit 87: New England Biolabs Inc. - Overview
Exhibit 88: New England Biolabs Inc. - Product/Service
Exhibit 89: New England Biolabs Inc. - Key news
Exhibit 90: New England Biolabs Inc. - Key offerings
10.8 Plexera LLC
Exhibit 91: Plexera LLC - Overview
Exhibit 92: Plexera LLC - Product/Service
Exhibit 93: Plexera LLC - Key offerings
10.9 Shimadzu Corp.
Exhibit 94: Shimadzu Corp. - Overview
Exhibit 95: Shimadzu Corp. - Business segments
Exhibit 96: Shimadzu Corp. - Key news
Exhibit 97: Shimadzu Corp. - Key offerings
Exhibit 98: Shimadzu Corp. - Segment focus
10.10 Sumitomo Bakelite Co. Ltd.
Exhibit 99: Sumitomo Bakelite Co. Ltd. - Overview
Exhibit 100: Sumitomo Bakelite Co. Ltd. - Business segments
Exhibit 101: Sumitomo Bakelite Co. Ltd. - Key offerings
Exhibit 102: Sumitomo Bakelite Co. Ltd. - Segment focus
10.11 Takara Bio Inc.
Exhibit 103: Takara Bio Inc. - Overview
Exhibit 104: Takara Bio Inc. - Business segments
Exhibit 105: Takara Bio Inc. - Key offerings
Exhibit 106: Takara Bio Inc. - Segment focus
10.12 Thermo Fisher Scientific Inc.
Exhibit 107: Thermo Fisher Scientific Inc. - Overview
Exhibit 108: Thermo Fisher Scientific Inc. - Business segments
Exhibit 109: Thermo Fisher Scientific Inc. - Key news
Exhibit 110: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 111: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 112: Inclusions checklist
Exhibit 113: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 114: Currency conversion rates for US$
11.4 Research methodology
Exhibit 115: Research methodology
Exhibit 116: Validation techniques employed for market sizing
Exhibit 117: Information sources
11.5 List of abbreviations
Exhibit 118: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Drug discovery and development - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Drug discovery and development - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Disease diagnostics - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Disease diagnostics - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Disease diagnostics - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Disease diagnostics - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Application ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Market opportunity By Geographical Landscape ($ million)
Exhibits 63: Impact of drivers and challenges in 2021 and 2026
Exhibits 64: Overview on Criticality of inputs and Factors of differentiation
Exhibits 65: Overview on factors of disruption
Exhibits 66: Impact of key risks on business
Exhibits 67: Vendors covered
Exhibits 68: Matrix on vendor position and classification
Exhibits 69: Agilent Technologies Inc. - Overview
Exhibits 70: Agilent Technologies Inc. - Business segments
Exhibits 71: Agilent Technologies Inc. - Key news
Exhibits 72: Agilent Technologies Inc. - Key offerings
Exhibits 73: Agilent Technologies Inc. - Segment focus
Exhibits 74: Asparia Glycomics S.L. - Overview
Exhibits 75: Asparia Glycomics S.L. - Product/Service
Exhibits 76: Asparia Glycomics S.L. - Key offerings
Exhibits 77: Bio Techne Corp. - Overview
Exhibits 78: Bio Techne Corp. - Business segments
Exhibits 79: Bio Techne Corp. - Key news
Exhibits 80: Bio Techne Corp. - Key offerings
Exhibits 81: Bio Techne Corp. - Segment focus
Exhibits 82: Merck KGaA - Overview
Exhibits 83: Merck KGaA - Business segments
Exhibits 84: Merck KGaA - Key news
Exhibits 85: Merck KGaA - Key offerings
Exhibits 86: Merck KGaA - Segment focus
Exhibits 87: New England Biolabs Inc. - Overview
Exhibits 88: New England Biolabs Inc. - Product/Service
Exhibits 89: New England Biolabs Inc. - Key news
Exhibits 90: New England Biolabs Inc. - Key offerings
Exhibits 91: Plexera LLC - Overview
Exhibits 92: Plexera LLC - Product/Service
Exhibits 93: Plexera LLC - Key offerings
Exhibits 94: Shimadzu Corp. - Overview
Exhibits 95: Shimadzu Corp. - Business segments
Exhibits 96: Shimadzu Corp. - Key news
Exhibits 97: Shimadzu Corp. - Key offerings
Exhibits 98: Shimadzu Corp. - Segment focus
Exhibits 99: Sumitomo Bakelite Co. Ltd. - Overview
Exhibits 100: Sumitomo Bakelite Co. Ltd. - Business segments
Exhibits 101: Sumitomo Bakelite Co. Ltd. - Key offerings
Exhibits 102: Sumitomo Bakelite Co. Ltd. - Segment focus
Exhibits 103: Takara Bio Inc. - Overview
Exhibits 104: Takara Bio Inc. - Business segments
Exhibits 105: Takara Bio Inc. - Key offerings
Exhibits 106: Takara Bio Inc. - Segment focus
Exhibits 107: Thermo Fisher Scientific Inc. - Overview
Exhibits 108: Thermo Fisher Scientific Inc. - Business segments
Exhibits 109: Thermo Fisher Scientific Inc. - Key news
Exhibits 110: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 111: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 112: Inclusions checklist
Exhibits 113: Exclusions checklist
Exhibits 114: Currency conversion rates for US$
Exhibits 115: Research methodology
Exhibits 116: Validation techniques employed for market sizing
Exhibits 117: Information sources
Exhibits 118: List of abbreviations

Executive Summary

The Publisher Announces the Publication of its Research Report - Global Glycobiology Market 2022-2026

The publisher recognizes the following companies as the key players in the global glycobiology market: Agilent Technologies Inc., Asparia Glycomics S.L., Bio-Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, Glycosensors and Diagnostics LLC, ICE S.p.A., Ludger Ltd, Merck KGaA, New England Biolabs Inc., Plexera LLC, RayBiotech Life Inc., Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., and Z Biotech LLC.

Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is advancements in the field of glycobiology.'

According to the report, one of the major drivers for this market is the growing prevalence of cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.